IL6 and diabetes mellitus: A large sample study showed that the risk of cardiovascular disease, pneumonia, diabetes, and lung cancer increased by 2–4 folds with a systemic inflammation measured by six inflammatory markers (CRP, IL-6, CXCL8, fibrinogen, TNF-α, and leukocytes).